See more
What is Sofy at right now?
Stock Quote (U.S.: Nasdaq) | MarketWatch....$ 5.83.CloseChgChg %$5.95-0.09-1.49%
Why is SoFi stock up?
Sofi Technologies SOFI –5.93% stock was spiking Monday after it was upgraded by Piper Sandler analyst Kevin Barker, who said the market may be over-discounting the financial services company's growth potential.
Why is SoFi tanking today?
SoFi stock falls after fintech firm accidentally releases first-quarter report early. Shares of SoFi fell sharply on Tuesday and were halted for nearly three hours after the company accidentally released its first-quarter results early. The company said the report was released early due to human error.
Who bought SoFi stock?
CEO Anthony NotoConsistent buys over the past month Starting on May 13, CEO Anthony Noto began buying SoFi shares, adding to his stake on dips, for a cumulative addition of more than 350,000 shares over the past month for more than $2 million, increasing his stake by more than 11%.
Is SoFi still a buy?
Fintech giant, SoFi Technologies (NASDAQ:SOFI) stock remains a fan-favorite investment choice for both retail and Institutional investors. SOFI has undeniably had a rough 2022 so far, much like other tech and growth stocks-the tech-heavy Nasdaq Composite is down 22% year-to-date.
What does SoFi stand for?
What does SoFi stand for? SoFi stands for Social Finance Inc., the company's original name at the time of its founding. The company now does business under the name SoFi Technologies, Inc.
Is SoFi stock oversold?
SoFi Technologies is Now Oversold (SOFI) | Nasdaq.
Is SoFi overvalued?
Shares of Robinhood Markets (HOOD), SoFi Technologies (SOFI), and PagSeguro Digital (PAGS) look overvalued at their current price levels. So, we think it could be wise to avoid them now.
Who is SoFi merging with?
Social Capital HedosophiaAs expected, Social Capital Hedosophia shareholders on Thursday approved the merger between SoFi and their company. Social Capital Hedosophia is a special purpose acquisition company (SPAC), an entity that basically exists to bring a privately held company onto the stock market.
Why did SoFi acquire Galileo?
The acquisition serves SoFi's greater vision of becoming the 'AWS of fintech'. The vision manifests in its banking as a service division Galileo becoming able to provide everything a company would need to get the ball rolling on launching a financial product.
Who are SoFi competitors?
SoFi's top competitors include Funding Circle, Avant, Lending Club, Upstart and LendingTree. SoFi Technologies is a finance company providing lending and wealth management services.
Why did SoFi stock drop today?
Shares of SoFi Technologies plunged more than 8% Tuesday after the fintech said it is buying the banking software provider Technisys for $1.
How has Direxion Daily Healthcare Bull 3x Shares' stock price performed in 2022?
Direxion Daily Healthcare Bull 3x Shares' stock was trading at $144.99 at the start of the year. Since then, CURE shares have decreased by 24.7% an...
Is Direxion Daily Healthcare Bull 3x Shares a good dividend stock?
Direxion Daily Healthcare Bull 3x Shares(NYSEARCA:CURE) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.06%. Vi...
What other stocks do shareholders of Direxion Daily Healthcare Bull 3x Shares own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily Healthcare Bull 3x Shares investors own incl...
What is Direxion Daily Healthcare Bull 3x Shares' stock symbol?
Direxion Daily Healthcare Bull 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CURE."
Who are Direxion Daily Healthcare Bull 3x Shares' major shareholders?
Direxion Daily Healthcare Bull 3x Shares' stock is owned by many different retail and institutional investors. Top institutional investors include...
Which institutional investors are selling Direxion Daily Healthcare Bull 3x Shares stock?
CURE stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP, Traynor Capital Management Inc., and El...
Which institutional investors are buying Direxion Daily Healthcare Bull 3x Shares stock?
CURE stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Jane Street Group LLC, Goldman...
How do I buy shares of Direxion Daily Healthcare Bull 3x Shares?
Shares of CURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Direxion Daily Healthcare Bull 3x Shares' stock price today?
One share of CURE stock can currently be purchased for approximately $109.18.
How much did Coursera IPO raise?
This was the high end of the initial pricing range, which has been set between $30 and $33. Overall, the IPO raised $519 million, before expenses. At the beginning of May, Coursera released its first quarterly report since going public.
What is the most successful hedge fund in history?
The hedge fund he founded, Soros Fund Management, earned an average annualized return of 33% from 1970 to 2020, making it the most successful hedge fund in history. Soros’s biggest single success came on September 16, 1992, when he ‘broke the Bank of England.’.
How has Direxion Daily Healthcare Bull 3x Shares' stock been impacted by Coronavirus (COVID-19)?
Direxion Daily Healthcare Bull 3x Shares' stock was trading at $50.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CURE shares have increased by 146.9% and is now trading at $123.92. View which stocks have been most impacted by COVID-19.
Is Direxion Daily Healthcare Bull 3x Shares a good dividend stock?
Direxion Daily Healthcare Bull 3x Shares pays an annual dividend of $0.03 per share and currently has a dividend yield of 0.03%. View Direxion Daily Healthcare Bull 3x Shares' dividend history.
What other stocks do shareholders of Direxion Daily Healthcare Bull 3x Shares own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily Healthcare Bull 3x Shares investors own include Direxion Daily Gold Miners Index Bull 2x Shares (NUGT), Alibaba Group (BABA), salesforce.com (CRM), Netflix (NFLX), Oracle (ORCL), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Teladoc Health (TDOC), Tesla (TSLA), Twilio (TWLO) and UnitedHealth Group (UNH)..
What is Direxion Daily Healthcare Bull 3x Shares' stock symbol?
Direxion Daily Healthcare Bull 3x Shares trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CURE."
Who are Direxion Daily Healthcare Bull 3x Shares' major shareholders?
Direxion Daily Healthcare Bull 3x Shares' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Traynor Capital Management Inc.
Which institutional investors are selling Direxion Daily Healthcare Bull 3x Shares stock?
CURE stock was sold by a variety of institutional investors in the last quarter, including Qube Research & Technologies Ltd, and Traynor Capital Management Inc.. View insider buying and selling activity for Direxion Daily Healthcare Bull 3x Shares or view top insider-selling stocks.
Which institutional investors are buying Direxion Daily Healthcare Bull 3x Shares stock?
CURE stock was purchased by a variety of institutional investors in the last quarter, including TAP Consulting LLC, and Cutler Group LP. View insider buying and selling activity for Direxion Daily Healthcare Bull 3x Shares or or view top insider-buying stocks.
What is cure pharmaceutical?
("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated specialty pharmaceutical company, announced today successful results from its initial Pharmacokinetics (PK)/bioequivalence studies. CURE will now advance its clinical program with the objective of U.S. Food and Drug Administration (FDA) approval.
When is cure webcast?
(OTC: CURR), a vertically integrated drug delivery and product development company, today announced that it will hold a webcast with the investment community on Thursday, May 27, at 5 p.m. Eastern Daylight Time.
Who is Curr 2021?
OXNARD, Calif., Jun 15, 2021--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today that its Chief Business Officer Jonathan Berlent will participate in a virtual presentation at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on Thursday, June 17.
When will Carnival Breeze return?
That will be followed by the return to operations of Carnival Breeze on July 15. Cruise guests will be required to show proof of vaccination for COVID-19. 2. Royal Caribbean Group: Royal Caribbean Group, formerly known as Royal Caribbean Cruises, operates a fleet of vessels in the cruise vacation industry.
Is cruise line stock outperforming the market?
However, as vaccines are rolled out, investors are becoming increasingly optimistic about the industry again. One cruise line stock that trades in the U.S. is currently outperforming the broader market on an annual basis.
What is a curo?
(NYSE: CURO) ("CURO" or the "Company"), a tech-enabled, multi-channel and multi-product consumer finance company serving a wide range of non-prime and prime consumers in the U.S. and Canada and a market leader in the industry based on revenue, today announced financial results for its first quarter ended March 31, 2021.
What is CURO Group?
(NYSE: CURO) ("CURO" or the "Company"), a tech-enabled, omni-channel consumer finance company serving a full spectrum of non-prime and prime consumers in the U.S. and Canada, today updated selected financial outlook for the second quarter of 2021 and announced a rationalization of its U.S.
MINDCURE Announces Strategic Review
Mind Cure Health Inc.
MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology for mental health care and research in psychedelics, announced today the hiring of Dr.
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, today announced its financial results and operational highlights for the three and six months ended November 30, 2021.
MINDCURE to Participate in the H.C. Wainwright Bioconnect Conference in January 2022
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, today announced that President & Chief Executive Officer, Kelsey Ramsden, will present virtually at the H.C. Wainwright Bioconnect Conference taking place on January 10-13, 2022.
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the December 16th Life Sciences Virtual Investor Conference are now available for on-demand viewing.
MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, announced today that the Company and its digital therapeutics technology, iSTRYM, have been certified as Health Insurance Portability and Accountability Act (HIPAA) compliant.
Virtual Conference for Life Sciences Companies Broadcast Live December 16th
Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world.
